Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Nuvo Group is commercializing INVU, a prescription-initiated remote pregnancy-monitoring platform. INVU combines proprietary hardware for high-fidelity data collection and innovative software solutions powered by AI tools in order to optimize the pregnancy care experience on a global scale.
INVU received 510(k) clearance from the U.S. FDA in March 2020 for maternal and fetal heart rate monitoring. Nuvo recently completed enrollment in pivotal trials to support an additional application for clearance for remote monitoring of uterine activity.